HLA-DR4
human major histocompatibility complex, class II, DR4
| |
Haplotypes groups | DRA*01:DRB1*04:01 to DRA*01:DRB1*04:13 |
Structure (See HLA-DR) | |
Identifiers | alpha *01:01
|
Symbol(s) | HLA-DRA[permanent dead link] |
EBI-HLA | DRA*01:01 |
Identifiers | beta 1 *04:01 to *04:13
|
Symbol(s) | HLA-DRB1[permanent dead link] |
EBI-HLA | DRB1*04:01 |
EBI-HLA | DRB1*04:02 |
EBI-HLA | DRB1*04:03 |
EBI-HLA | DRB1*04:04 Archived 2011-05-15 at the Wayback Machine |
EBI-HLA | DRB1*04:05 |
EBI-HLA | DRB1*04:06 |
EBI-HLA | DRB1*04:07 Archived 2011-05-15 at the Wayback Machine |
EBI-HLA | DRB1*04:08 |
EBI-HLA | DRB1*04:09 Archived 2011-05-15 at the Wayback Machine |
EBI-HLA | DRB1*0410 |
EBI-HLA | DRB1*0411 |
EBI-HLA | DRB1*0412 |
EBI-HLA | DRB1*0413 |
Shared data | |
Locus | chr.6 6p21.31
|
HLA-DR4 (DR4) is an HLA-DR serotype that recognizes the DRB1*04 gene products. The DR4 serogroup is large and has a number of moderate frequency alleles spread over large regions of the world.
Serology
DRB1* | DR4 | Sample |
allele | % | size (N) |
04:01 | 98 | 5118 |
04:02 | 92 | 1029 |
04:03 | 92 | 748 |
04:04 | 89 | 2164 |
04:05 | 91 | 505 |
04:06 | 89 | 83 |
04:07 | 86 | 846 |
04:08 | 86 | 258 |
04:09 | 95 | 13 |
04:10 | 84 | 29 |
04:11 | 93 | 76 |
04:12 | >50 | 1 |
04:13 | >30 | 3 |
The serological identification of DR4 is good. The serology of DRB1*04:17 to *04:60 is unknown.
Disease associations
By serotype
DR4 is associated with extraarticular
By allele
DRB1*04 is associated with increased risk for alopecia areata.[11]
DRB1*04:01 is associated with multiple sclerosis,[12] rheumatoid arthritis,[13] type 1 diabetes,[14][15] lyme disease induced arthritis.[16] HLA-DRB1*04:01 gene variant is found three times more often in asymptomatic carriers of SARS-CoV-2 than in patients with symptoms of COVID-19. It is known that the prevalence of the HLA-DRB1*04:01 variant directly correlates with the latitude and longitude of the population. This variant of the gene is more common in northern and western Europe, which means that people of European descent are more likely to be asymptomatic carriers that can transmit the disease to more susceptible populations.[17]
DRB1*04:02: drug-triggered[18]/idiopathic pemphigus vulgaris,[19][20] type 1 diabetes,[15] SLE associated anti-cardiolipin and anti-β2 glycoprotein I.[21]
DRB1*04:03: polycystic ovary syndrome,[22] SLE associated anti-cardiolipin and anti-β2 glycoprotein I.[23]
DRB1*04:04: anti-citrullinated fibrinogen[24] in rheumatoid arthritis,[13] autoimmune hepatitis.[25]
DRB1*04:05: rheumatoid arthritis,[26] Autoimmune hepatitis,[27] type 1 diabetes.[14][15]
DRB1*04:06: caspase-8 autoantibodies silicosis-systemic sclerosis (SSc)-systemic lupus erythematosus (SLE).[28]
DRB1*04:09: T. cruzi infection with cardiomyopathy.[29]
By haplotype
DR4-DQ8 is a risk factor for papillary thyroid carcinoma,[30] juvenile diabetes, coeliac disease and rheumatoid arthritis.[31]
DRB1*04:DQA1*03:03-DQB1*04:01 haplotype: type III autoimmune polyglandular syndrome,[32] autoimmune hepatitis,[33] autoimmune pancreatitis.[34]
DRB1*04:DQA1*03-DQB1*03:02 haplotype: Type 1 diabetes[35][36] with DRB1*04:01, *04:05, *04:02 increasing risk when DQ8 is present.[37]
By genotype
DRB1*01:01/*04:04 and *01:01/*04:01 increases risk of mortality in rheumatoid arthritis, with ischemic heart disease and smoking.[38] these same genotypes are associated with rheumatoid vasculitis.[39]
Genetic linkage
DR4 Haplotypes
| ||||
Serotypes | DRA | DRB1 | DRB4 | |
---|---|---|---|---|
DR4-DR53 | *01:01 | *04:01 | *01:03 | |
*01:01 | *04:02 | *01 | ||
*01:01 | *04:03 | *01 | ||
*01:01 | *04:04 | *01 | ||
*01:01 | *04:05 | *01 | ||
Serotypes | DQA1 | DQB1 | DRB1 | |
DR4-DQ7 (7.3, 3) | *03:03 | *03:01 | *04:01 | |
DR4-DQ7 (8.1, 3) | *03:01 | *03:02 | *04:01 | |
*03:01 | *03:02 | *04:02 | ||
*03:01 | *03:02 | *04:04 | ||
DR4-DQ4 (4.3) | *03:03 | *04:01 | *04:05 | |
Serotypes | HLA-A | HLA-C | HLA-B | DRB1 |
A2 -Cw10-B62(15)-DR4 |
*02:01 | *03:04 | *1501 | *04:01 |
A2 -Cw10-B60(40)-DR4 |
*02:01 | *03:04 | *4001 | *04:02 |
A2 -Cw5-B44(16)-DR4 |
*02:01 | *05:01 | *44:02 | *04:01 |
References
- ^ derived from IMGT/HLA
- PMID 16542468.
- S2CID 21303372.
- S2CID 27312391.
- S2CID 10047304.
- S2CID 40684479.
- PMID 6954729.
- PMID 6217371.
- PMID 17384178.
- ISBN 978-0-7817-7153-5.
- PMID 16935791.
- S2CID 35854155.
- ^ PMID 1429034.
- ^ PMID 8475491.
- ^ PMID 8971095.
- PMID 9685265.
- PMID 33896121.
- PMID 7747528.
- PMID 17389015.
- PMID 16698434.
- S2CID 208624924.
- S2CID 34179090.
- S2CID 208624924.
- PMID 16255019.
- PMID 9672174.
- S2CID 21900892.
- S2CID 39851212.
- PMID 15703453.
- S2CID 41178678.
- S2CID 22695710.
- PMID 1371662.
- S2CID 43559284.
- PMID 15763345.
- PMID 11984513.
- S2CID 38178367.
- PMID 12889996.
- PMID 17610416.
- PMID 17469097.
- PMID 15529352.